Godwin, Mike. <br/><br/>
Prescription Panic. / 
Mike Godwin. 
 -  Reason,  2002. 
 - SIRS Enduring Issues 2003.  Article 64.  Business,  1522-3191; .
<br/><br/> Articles Contained in SIRS Enduring Issues 2003.  Originally Published: Prescription Panic, Feb. 2002; pp. 32-37. 
<br/><br/> "Before September 11 [2001], U.S. policy toward pharmaceutical patents was clear: The interests of the patent holder came first. However, the anthrax scare that surfaced in October has managed to shake that policy to its roots." (REASON) This article discusses how a public health scare can change policies related to pharmaceutical patents. 
<br/><br/><label>ISSN: </label>1522-3191; 
<br/><br/><label>Subjects--Corporate Names: </label><br/>Bayer Corporation.
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anthrax.<br/>Ciprofloxacin.<br/>Drugs--Law and legislation.<br/>Intellectual property.<br/>Patents.<br/>Pharmaceutical industry.<br/>Prescription drugs.<br/>Public health.
<br/><br/><label>LC Class. No.: </label>AC1.S5 
<br/><br/><label>Dewey Class. No.: </label>050